Results from a three-year trial suggest an experimental gene therapy for Huntington's disease can slow the progression of the ...

In a trial of people with early Huntington's, the newly developed therapy slowed the progression of symptoms by 75%.

Seniors with high levels of psychological and emotional wellness are more likely to regain their overall well-being after ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...

Clinical trials of a groundbreaking new gene therapy for Huntington's disease have shown that it slows progression of the ...

A study led by Vincenzo Condello and Christofer Juhlin of the Karolinska Institutet explores why some papillary thyroid ...

After three patients died, the maker of an investigational gene therapy stopped shipments of the drug after it refused to ...

Ten-year-old Sebastian Veiman is racing against time to receive €2.5 million gene therapy that could halt — or even reverse — ...

Danicamtiv is an investigational selective agonist of cardiac myosin, intended to help myocyte contraction by enhancing ...

In a conversation with THE WEEK, Dr Kshitija Patil highlights the challenges in diagnosis, prevention, and therapy, ...

A new gene therapy treatment developed by uniQuire has shown promise in reducing the progression of Huntington’s Disease by ...

Three draft recommendation documents published on Wednesday are intended to guide drug sponsors and accelerate the ...